4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-049446
Chief Executive Officer acquired 5,908 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2017-08-15 | Option exercise | +5,908 | 737,767 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2017-08-15 | Option exercise · Restricted Stock Units | −5,908 | 9,846 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…